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Abstract
Background
Immunochromatographic card test (ICT) is a tool to map the distribution ofWuchereria ban-
crofti. In areas highly endemic for loaisis in DRC and Cameroon, a relationship has been
envisaged between high L. loamicrofilaria (Mf) loads and ICT positivity. However, similar
associations have not been demonstrated from other areas with contrasting levels of L. loa
endemicity. This study investigated the cross-reactivity of ICT when mapping lymphatic fila-
riasis (LF) in areas with contrasting endemicity levels of loiasis and mansonellosis in
Cameroon.
Methodology/Principal Findings
A cross-sectional study to assess the prevalence and intensity ofW. bancrofti, L. loa andM.
perstans was carried out in 42 villages across three regions (East, North-west and South-
west) of the Cameroon rainforest domain. Diurnal blood was collected from participants for
the detection of circulating filarial antigen (CFA) by ICT and assessment of Mf using a thick
blood smear. Clinical manifestations of LF were also assessed. ICT positives and patients
clinically diagnosed with lymphoedema were further subjected to night blood collection for
the detection ofW. bancroftiMf. Overall, 2190 individuals took part in the study. Overall, 24
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individuals residing in 14 communities were tested positive by ICT, with prevalence rates
ranging from 0% in the South-west to 2.1% in the North-west. Lymphoedema were diag-
nosed in 20 individuals with the majority of cases found in the North-west (11/20), and none
of them were tested positive by ICT. No Mf ofW. bancrofti were found in the night blood of
any individual with a positive ICT result or clinical lymphoedema. Positive ICT results were
strongly associated with high L. loaMf intensity with 21 subjects having more than 8,000 L.
loaMf ml/blood (Odds ratio = 15.4; 95%CI: 6.1–39.0; p < 0.001). Similarly, a strong positive
association (Spearman’s rho = 0.900; p = 0.037) was observed between the prevalence of
L. loa and ICT positivity by area: a rate of 1% or more of positive ICT results was found only
in areas with an L. loaMf prevalence above 15%. In contrast, there was no association
between ICT positivity andM. perstans prevalence (Spearman’s rho = - 0.200; p = 0.747)
and Mf density (Odds ratio = 1.8; 95%CI: 0.8–4.2; p = 0.192).
Conclusions/Significance
This study has confirmed the strong association between the ICT positivity and L. loa inten-
sity (Mf/ml of blood) at the individual level. Furthermore, the study has demonstrated that
ICT positivity is strongly associated with high L. loa prevalence. These results suggest that
the main confounding factor for positive ICT test card results are high levels of L. loa. The
findings may indicate thatW. bancrofti is much less prevalent in the Central African region
where L. loa is highly endemic than previously assumed and accurate re-mapping of the
region would be very useful for shrinking of the map of LF distribution.
Author Summary
Mapping of lymphatic filariasis (LF) caused byW. brancrofti is usually done by employing
a rapid diagnostic test that permits the detection of worm antigen in daytime blood. This
is sometimes combined with a thick blood film (TBF) for microscopic examination, as
confirmatory tool for detectingW. bancroftiMf in peripheral night blood. During recent
epidemiological surveys using immunochromatographic card test (ICT) to map LF in
areas highly endemic for loiasis, positive card tests were observed in individuals’ amicrofi-
laremic forW. bancrofti during night TBF examination, as well as by parasite DNA detec-
tion. The possibility of ICT cross-reacting with L. loa antigen was envisaged, but so far
associations between ICT positivity and L. loa endemicity levels and loads of Mf in day
blood have not yet been established. Moreover,M. perstans another filaria with blood
dwelling Mf, that is often sympatric with L. loa, could contribute to the observed ICT
cross-reactivity. The authors investigated the cross-reactivity of ICT in areas with contrast-
ing endemicity levels of L. loa andM. perstans in Cameroon. Results incriminated L. loa as
the major confounder in ICT cross-reactivity, with significant association between ICT
positivity and loiasis both at individual level (load of Mf/ml of blood) and endemicity level
(Mf prevalence).M. perstans displayed no association with ICT positivity. The findings
raised concerns about the specificity of the whole blood ICT used for LF mapping in loiasis
co-endemic areas. The development of an algorithm for LF mapping in loiasis co-endemic
areas will be important to validate the LF map obtained using ICT in Central Africa.
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Introduction
Lymphatic filariasis (LF) is a chronic, debilitating vector-borne disease that affects about 68
million people in 73 countries in tropical and subtropical areas of Asia, Africa, the Western
Pacific and some areas of the Americas. The disease is caused by the filarial parasitesWucher-
eria bancrofti, Brugia malayi and B. timori, which are transmitted by Culex, Anopheles and
Mansoniamosquitoes [1]. In Africa, about 44 million people are currently estimated to be
infected withW. bancrofti [2]. While no human Brugia species occurs in Africa, the geographic
distribution ofW. bancrofti overlaps considerably with that of the other four African filarial
species [3–5]. With its diverse bio-ecological zones, Cameroon is one of the few countries
world-wide that is endemic for five human filarial species:W. bancroftimicrofilariae (Mf)
mainly in night blood,Mansonella perstans and Loa loaMf mainly in day blood, and Oncho-
cerca volvulus andMansonella streptocercaMf in the skin [6].
The presence of circulating Mf in peripheral blood is a prerequisite for the transmission of
LF. Elimination efforts of LF therefore focus on the interruption of transmission by decreasing
the prevalence of persons with Mf in the population. In 1997, the World Health Assembly tar-
geted LF for elimination through a strategy of mass drug administration (MDA). In Africa
where onchocerciasis is co-endemic a single-dose, annual administration of ivermectin
(donated by Merck & Co., Rahway, NJ) combined with albendazole (donated by GlaxoSmithK-
line, Bentford, UK) is recommended for reducing Mf [7,8]. Henceforth, WHO recommended
to provide MDA to the entire population at risk of infection in areas with LF prevalence of 1%
or higher [7,9–11]. However, accurate mapping of the distribution of infection is crucial for
implementation as well as for monitoring and evaluation of the MDA programme.
Historically, detection of Mf by microscopy has been used for the identification of endemic
areas. However, parasitological methods to detect Mf require night blood and are time con-
suming, cumbersome and insensitive [12–14]. Circulating filarial antigen (CFA) tests are now
considered the method of choice for the detection ofW. bancrofti infection [15]. CFA can be
detected in day blood, and also in individuals that harbour adult worms, few or no Mf. A labo-
ratory-based and two rapid diagnostic filarial antigen tests are now commercially available,
and detect a similar epitope. Og4C3 ELISA is a laboratory test using a monoclonal antibody
(MAb) of the IgM class against the bovine parasite Onchocerca gibsoni. Although this tech-
nique allowed for the identification ofW. bancrofti antigens in serum, plasma and hydrocele
fluid [16–19]; it is time consuming, expensive and non-convenient for a rapid assessment of LF
endemicity. The Filariasis ICT is a rapid diagnostic test, which uses a MAb (AD12) raised
against the dog heartworm Dirofilaria immitis to detect circulatingW. bancrofti antigen in
blood [15]. The test is easy to perform in community settings, and requires no equipment since
it comes in a convenient kit format. The ICT has been used as a major tool for mapping, moni-
toring and evaluation within the Global Programme to Eliminate of Lymphatic Filariasis
(GPELF) [5,10,20–23]. Recently, a more sensitive strip test version of the card test that uses the
same major reagents became available, and has been evaluated so far in Liberia, Sri Lanka and
Indonesia [24,25].
Elimination of LF and onchocerciasis in western and central Africa where loiasis is co-
endemic is a problem, because ivermectin that is used for MDAmay cause severe adverse
events in individuals with high L. loaMf loads [26–29]. Therefore, GPELF has not been imple-
menting MDA in many parts of western and central Africa. More difficulties in the advance-
ment of activities of GPELF in this region, have arisen from the incomplete or inaccurate
mapping. The ICT has to be read strictly after a 10 minutes incubation period and longer peri-
ods can produce false positive test results [30]. Moreover, another problem has recently been
reported exclusively from areas with high L. loaMf prevalence in Democratic Republic of
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Congo (DRC). Bakajika et al. [24] observed cross-reaction of the ICT with individuals that har-
boured large numbers of L. loaMf in night blood, without any evidence for LF infection in the
study villages. This cross-reactivity with L. loa antigen was also described in a L. loa hyper-
endemic area in Cameroon [31]. The absence of bancroftian filariasis was proven using both
parasitological, and molecular diagnosis.
During the development phase of the ICT, its specificity was tested extensively using sera
from patients with various filarial infections, including loiasis [15]. However, the tested loiasis
sera were mainly from expats with low Mf densities. The test was not evaluated in areas highly
endemic for loiasis, using sera of individuals with high L. loaMf counts. Moreover, the contri-
bution ofM. perstans, another filarial parasite with blood dwelling Mf, to the ICT cross-reactiv-
ity was not fully resolved. The present study was designed to re-evaluate LF endemicity as
assessed by the ICT in areas with contrasting endemicity rates of loiasis and mansonellosis in
Cameroon. Data were analysed with the following considerations: (i) association between L.
loaMf prevalence and the rate of ICT positivity in areas of contrasting endemicity of loiasis;
(ii) association betweenM. perstansMf prevalence and the rate of ICT positivity in areas of
contrasting endemicities of mansonellosis; (iii) correlation between L. loaMf densities (Mf/ml
of blood) and the rate of ICT positivity at the individual level; (iv) Correlation betweenM. per-
stansMf densities (Mf/ml of blood) and the rate of ICT positivity at the individual level; and
(v) threshold of risk of ICT card positivity due to L. loa andM. perstans prevalence and
intensity.
Methods
Study sites
Data were collected between March and September 2013 in 42 villages across seven health dis-
tricts (HDs) in the East (two HDs), North-west (one HD) and South-west (four HDs) regions,
located in the Cameroon rainforest belt (Fig 1). The pre-control LF survey data in these study
sites showed LF prevalence of 1% and above. These villages are situated in areas of contrasting
endemicity of loiasis and mansonellosis. In the East region, Messamena and Batouri HDs are
areas of high endemicity for both L. loa andM. perstan. The Nwa HD in the North-west is
highly endemic for loiasis with very low endemicity forM. perstans. In the South-west region,
four health districts with different profiles of endemicities for loiasis and mansonellosis ende-
micities were chosen: Kumba-Konye HDs, with low endemicity for both L. loa andM. perstans
and the Mamfe-Eyumodjock HDs with low endemicity for loaisis and intermediate to high
endemicity level for mansonellosis. Except Batouri, which is a naïve HD to ivermectin MDA,
the remaining six HDs are under ivermectin MDA for onchocercasis elimination, and the most
recent ivermectin MDA took place one to two months before the survey. The ivermectin treat-
ment history in the study area is documented in S1 Table. Ivermectin clears L. loaMf andW.
bancroftiMf at similar rates and it is likely that Individuals with high L. loaMf counts did not
participate in MDA.
Study design and population
Data were collected using a cross-sectional community-based design (Fig 2). In each village, at
least 100 residents, both males and females (10 years of age and older) were screened during
the day for the presence ofW. bancrofti antigenaemia using the ICT (Alere, Scaborough, ME,
USA). Daytime thick blood smear were prepared from each participant to assess their blood
dwelling Mf. All study participants were examined for lymphoedema and hydrocele. Individu-
als tested positive in the ICT and lymphoedema/hydrocele cases, were further submitted to
night thick blood film examination for search ofW. bancroftiMf in the blood.
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Ethical considerations
The protocol used for this study received ethical approval from the Cameroon National ethics
committee (CNEC) and administrative approval from the Ministry of Public Health of Camer-
oon. In the study communities, details were given about potential risks and benefits of the
study to the community leaders and study participants. It was explained that participation was
voluntary; hence people could withdraw anytime without further obligations. When the head
of household or the person involved in the serological survey was well educated and willing to
sign documents, investigators provided a written informed consent form which was then
signed. However, due to high illiteracy rate and cultural reasons (i.e. signatures or finger prints
are linked to elections or court orders), oral informed consent was obtained in many cases
from each person participating in the clinical, serological and parasitological examination. The
researcher presented the consent information to the participant referring to the bullet points
listed on the consent form, and answered any questions he had. The CNEC approved these
procedures and if the participant gives consent, it was recorded in the researcher’s notes. If less
than 21 years old (age of majority in Cameroon) the verbal assent and permission were
obtained from the study participant and legal guardians respectively. The data were analysed
and reported, to exclude any directly identifiable information, in order to maintain the ano-
nymity of the participants.
Fig 1. Map of the study area.
doi:10.1371/journal.pntd.0004184.g001
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Clinical examination
Trained medical personnel recruited for this study examined all the participants for lymphoe-
dema. All males were examined for signs of the limb lymphoedema and hydrocele and female
for limb lymphoedema [32].
Fig 2. Study design.
doi:10.1371/journal.pntd.0004184.g002
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Circulating filarial antigen examination
The ICT cards were stored at 8°C and carried to the field in polystyrene foam boxes. In each
community, the blood from eligible participants was tested in the field by ICT according to the
manufacturer’s instructions. Briefly, 100μL of heparinized capillary blood obtained during the
day between 10am and 3pm, from each person by finger pricking was applied to the sample
application pad of the ICT. The reading was taken strictly after 10 minutes. A single test was
performed for each participant.
Parasitological examination
Diurnal and nocturnal blood collections were performed between 10am-3pm and 10pm-12am,
respectively. At daytime, 50μL non-heparinized finger-prick blood was used to assess Mf by
thick blood film (TBF). During the night, two separate non-heparinized finger-prick blood
samples of approximately 50μL were collected from all ICT positives and all lymphoedema/
hydrocele cases to carry out TBF. The blood was drawn onto a microscope slide, allowed to dry
and stained with 10% Giemsa using standard procedures [6]. The stained smears were exam-
ined using a light microscope at 10× objective for blood dwelling Mf: L. loa andM. perstans for
daytime TBF andW. bancrofti, L. loa andM. perstans for night TBF. Microfilariae were identi-
fied (when need using 40× or 100× objectives), quantified and recorded.
Statistical analysis
Data were compiled and managed using EpiInfo v3.5.3 (Centers for Disease Control and Pre-
vention, Atlanta, GA) and imported to SPSS v20.0.0 (Armonk, NY: IBM Corp) for analysis.
The geometric mean intensity (GMI) of Mf counts was calculated as antilog (∑log(x+1)/n),
with "x" being the number of Mf per mL of blood in Mf positive individuals and "n" the number
of Mf positive individuals examined. Unless otherwise stated, all statistically significant associa-
tions were determined by setting the probability of a Type I error at 5% (α = 0.05). Spearman
correlation analysis was carried out between ICT positivity rates and TBF data at both individ-
ual and district levels. Chi-square tests were used to compare dichotomous variables. The logis-
tic regression was performed to identify the predictors of ICT positivity in areas where L. loa
andM. perstans are co-endemic.
Results
Study population characteristics
Overall, 2190 participants underwent ICT testing. Of these, 48.6% (1065/2190) were male with
a mean age of 39.7 ± 19.2 years. The females (1125/2190) had a mean age of 39.6 ± 19.5years.
The majority of the participants enrolled were aged between 20 and 59 years (Fig 3).
Lymphoedema prevalence
Twenty (0.9%) lymphoedema cases were diagnosed in the entire study population, and none of
them tested positive by ICT for circulatingW. bancrofti antigen (Table 1). The Northwest site
had the highest lymphoedema prevalence (1.8%) followed by East sites (Messamena and
Batouri HDs with 1.4% and 0.6% prevalence respectively). Males were slightly more affected by
the lymphoedema condition than females (1.3% and 0.5% lymphoedema prevalence respec-
tively), but this difference was not statistically significant (p = 0.055). There was no significant
difference in lymphoedema prevalence with respect to age groups (p = 0.176) (Table 2). No sin-
gle case of hydrocele was observed in males.
Cross-Reactivity of the ICT Card Test in L. loa Endemic Areas
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Prevalence of positive ICT
Overall prevalence of positive ICT results was 1.1% (24/2190). This prevalence ranged from 0%
in the Mamfe-Eyumodjock HD (South-west region) to 2.1% in Nwa HD (North-west region)
(Table 1). Two out of seven HDs were found to be positive by ICT with rates greater or equal
to 1%: East-Batouri HD (1.8%); Northwest-Nwa HD (2.1%). Among the 42 communities sur-
veyed, 14 had a prevalence of positive ICT 1%, with 7 of these localized in the Nwa HD in
the North-west. One community in the Eastern region (Batouri HD) had a relatively high prev-
alence (Konga 11.1%). Point prevalence for each surveyed site is shown in S1, S2 and S3 Figs.
There were significantly more positive ICT tests in males (1.6%) compared to females (0.6%)
(p< 0.05). No significant difference (p = 0.053) was found in antigenaemia prevalence with
respect to age groups (Table 2).
Parasitological findings
Day blood. Diurnal blood collection results are also indicated in Table 1. In total, the L. loaMf
prevalence was 17.0% (372/2190) with a GMI of 839.5 Mf/ml of blood. The East-Batouri HD
(29.5%, 1809.4 Mf/ml GMI) and the North-west (25.9%, 1022.2 Mf/ml GMI) had the highest
endemicity levels. In the Southwest 1 (6.9%, 342.2 Mf/ml GMI) and 2 (6.1%, 430.7 Mf/ml
GMI) the prevalence of L. loaMf was lower. The point Mf prevalence in each site is shown in
S1–S3 Figs. The prevalence of L. loaMf was significantly associated with age (p< 0.001), but
no significant difference in L. loa infection rate (p = 0.067) was observed between males
(18.5%; 857.1 Mf/ml GMI) and females (15.6%; 820.2 Mf/ml GMI).
Mansonella perstansMf displayed a contrasting endemicity pattern in the study area with
high prevalence rates observed in the East (45.6%, 129.4 Mf/ml GMI) and Southwest 2 (16.8%,
81.8 Mf/ml GMI). The Southwest 1 (9.5%, 49.8 Mf/ml GMI) and Northwest (0.2%) showed
lower prevalence rates. The point prevalence ofM. perstansMf in each site is shown in S1–S3
Figs. Males had a significantly (p< 0.05) higher Mf prevalence (25%, 130.3 Mf/ml GMI)
Fig 3. Age distribution of the study population.
doi:10.1371/journal.pntd.0004184.g003
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Table 1. Positive results for antigen detection, clinical manifestations of lymphatic filariasis andmicrofilaraemia test.
Site Health
district
Community N° of
persons
examined
Number of
ICT positive
(%)
Number of
lymphoedema
cases (%)
Number of L.
loa Mf
positive (%)
L. loa Mf
GMI (Mf/
ml)
Number of M.
perstans Mf
positive (%)
M. perstans
Mf GMI (Mf/
ml)
EAST
Batouri
Dem 2 40 0 0 13 1245.8 14 57.4
Djal 44 0 0 14 2761.1 10 121.0
Gabaleta 47 0 0 8 1662.1 6 94.2
Kamba Mieri 60 0 0 16 2777.5 11 81.6
Konga 36 4 1 14 3220.8 24 201.4
Ngoulmekong 52 1 0 21 1272.4 29 168.1
Nguikouassima 63 1 1 15 1067.2 20 78.1
Total 342 6 (1.8) 2 (0.6) 101 (29.5) 1809.4 114 (33.3) 117.6
Messamena
Aviation 42 1 0 7 797.1 11 46.3
Bissoua 2 83 0 1 11 412.1 56 189.2
Doume Village 42 1 0 2 254.6 10 50.9
Koum 45 0 0 5 519.3 26 94.2
Labba 34 0 1 2 400.0 27 309.6
Mayos 75 0 0 6 42.0 39 129.1
Meba 47 0 3 12 121.0 35 159.6
Messamena
Village
36 0 0 3 559.1 22 147.3
Nkomzuh 12 0 0 0 - 6 70.5
Ntollock 52 0 1 11 147.8 14 34.8
Soleye 43 2 1 6 1642.0 29 164.9
Total 511 4 (0.8) 7 (1.4) 65 (12.7) 277.4 275 (53.8) 134.7
Total 853 10 (1.2) 9 (1.1) 166 (19.5) 868.2 389 (45.6) 129.4
NORTH-WEST
Nwa
Jator 41 1 0 6 2615.7 1 20
Mbiripkwa 57 2 2 18 652.4 0 -
Ngomkow 53 1 0 3 3311.1 0 -
Ngu 59 0 0 14 705.7 0 -
Nguri 68 2 7 30 1156.1 0 -
Nking 65 4 0 29 1798.7 0 -
Ntem 84 0 0 23 494 0 -
Nwanti 68 2 2 26 1156.7 0 -
Nwat 59 1 0 6 769.1 0 -
Sabongari 49 0 0 4 847.4 0 -
Total 614 13 (2.1) 11 (1.8) 159 (25.9) 1022.2 1 (0.2) 20
Table 1
concluded
Site Health
district
Community N° of
persons
examined
Number of
ICT positive
(%)
Number of
lymphoedema
cases (%)
Number of L.
loa Mf
positive (%)
L. loa Mf
GMI (Mf/
ml)
Number of M.
perstans Mf
positive (%)
M. perstans
Mf GMI (Mf/
ml)
(Continued)
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compared to females (19.6%, 96.8 Mf/ml GMI) andM. perstans infection rates were signifi-
cantly correlated with age (p< 0.001).
Night blood. Out of 43 (23 ICT positives and 20 lymphoedema cases) participants who
took part in the night blood collection, none were found positive forW. bancroftiMf. Rather,
L. loa andM. perstansMf were found in the night TBFs with 41.9% (18/43) and 27.9% (12/43)
Mf prevalence respectively.
Comparison of day and night microfilaraemia
Generally, L. loaMf GMI of ICT positives were higher than those of lymphoedema cases (ICT
negatives) meanwhile,M. perstansMf densities of this last group of individuals were higher as
compared to ICT positives. However, L. loaMf prevalence slightly decreased between day and
night blood examination (Loa-day TBF: 17/23; Loa-night TBF: 16/23). TheM. perstansMf rate
was not dependent of the time of blood collection (Table 3). L. loaMf GMI of ICT-positive
individuals decreased from daytime (14366.2 Mf/ml) to the night (1142 Mf/ml), given a reduc-
tion coefficient of 12.6, whereasM. perstansMf GMI doubled from daytime (100.2 Mf/ml) to
the night (202.7 Mf/ml). On the other hand, L. loa andM. perstans infection rates of lymphoe-
dema cases (ICT negatives) decreased from day to night, and the Mf densities of both filariae
increased between both time points (Table 4).
Table 1. (Continued)
SOUTH-WEST 1
Konye
Baduma 41 0 0 6 372.6 7 64
Bolo 51 0 0 2 20 8 53.6
Matondo 2 49 0 0 1 640 4 33.6
Weme 7 0 0 2 240 4 67.8
Total 148 0 0 11 (7.4) 212.3 23 (15.5) 54.3
Kumba
Ediki 98 1 0 4 787.3 8 36.4
Mbalangi 101 0 0 9 423.6 2 63.2
Total 199 1 (0.5) 0 13 (6.5) 512.6 10 (5) 40.6
Total 347 1 (0.3) 0 24 (6.9) 342.2 33 (9.5) 49.8
SOUTH-WEST 2
Eyumodjock
Ayukaba 45 0 0 2 174.4 6 68.8
Ebam 54 0 0 3 149.3 1 200
Mbatop 41 0 0 5 1128 5 64.9
Total 140 0 0 10 (7.1) 423.3 12 (8.6) 73.4
Mamfe
Bache 21 0 0 2 63.2 13 76.8
Eyanchang 55 0 0 1 7080 1 200
Kesham 40 0 0 2 2983.2 21 144.4
Mbakem 40 0 0 1 20 4 73.3
Taboh 80 0 0 7 456.7 12 34.8
Total 236 0 0 13 (5.5) 436.5 51 (21.6) 83.9
Total 376 0 0 23 (6.1) 430.7 63 (16.8) 81.8
No W. bancrofti Mf were found in ICT positive and lymphoedema cases.
doi:10.1371/journal.pntd.0004184.t001
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Loa loa andM. perstansMf periodicity with respect to the Mf load ranges in ICT positives
and lymphoedema cases is shown in Tables 5 and 6. Generally, ICT positive individuals with
high (> 8,000 Mf/ml) and very high (> 30,000 Mf/ml) L. loaMf density were found Loa TBF
positive both day and night, whereas the low Mf carriers (1–8,000 Mf/ml) were found Mf posi-
tive only during the day time.
Infection profile of ICT positive individuals and lymphoedema cases
Seventy five percent (18/24) of ICT card positive individuals were L. loaMf carriers with 41.7%
(10/24) harbouring L. loaMf only, and 33.3% (8/24) with both L. loa andM. perstansMf. Six
of these individuals had neither L. loa norM. perstansMf in their day-TBF (Table 7). In this
last group of individuals, 3 were from the North-west and 3 from the East-Messamena HD,
Table 2. Gender and age-related prevalence of ICT test card, lymphoedema and diurnal microfilaraemia (TBF).
N° of persons
examined
Number of ICT
positive (%)
Number of
lymphoedema cases
(%)
Number of L. loa
Mf positive (%)
L. loa Mf
GMI (Mf/ml)
Number of M.
perstans Mf positive
(%)
M. perstans Mf
GMI (Mf/ml)
By gender
Male 1065 6 (0.6) 14 (1.3) 197 (18.5) 857.1 266 (25.0) 130.3
Female 1125 18 (1.6) 6 (0.5) 175 (15.6) 820.2 220 (19.6) 96.8
By age
group
(years)
10–19 379 2 (0.5) 3 (0.8) 31 (8.2) 1116.0 64 (16.9) 71.6
20–29 390 6 (1.5) 2 (0.5) 81 (20.8) 981.2 70 (20.3) 69.3
30–39 363 4 (1.1) 2 (0.6) 54 (14.9) 860.4 58 (16.0) 102.3
40–49 349 3 (0.9) 2 (0.6) 70 (20.1) 772.9 72 (20.6) 95.0
50–59 292 2 (0.7) 2 (0.7) 45 (15.4) 590.2 84 (28.8) 158.2
60–69 221 1 (0.5) 4 (1.8) 47 (21.3) 908.7 65 (29.4) 147.8
70–79 139 3 (2.2) 4 (2.9) 28 (20.1) 869.5 46 (33.1) 257.6
80 + 57 3 (5.3) 1 (1.8) 16 (28.1) 583.0 18 (31.6) 159.0
No W. bancrofti Mf were found in ICT positive and lymphoedema cases.
doi:10.1371/journal.pntd.0004184.t002
Table 3. Comparison of day and night parasitological indices of ICT positive individuals.
L. loa Mf M. perstans Mf
Day Night Day Night
Examined
(n)
Mf positive
(%)
Mf GMI (Mf/
ml)
Mf positive
(%)
Mf GMI (Mf/
ml)
Mf positive
(%)
Mf GMI
(Mf/ml)
Mf positive
(%)
Mf GMI
(Mf/ml)
Health districts
East
Batouri-HD 6 6 12371.5 6 1242.7 6 131 6 265.7
Messamena-
HD
4 1 30160 1 280 1 20 1 40
North-west
Nwa-HD 13 10 14591.0 9 1261.8 0 - 0 -
Total 23* 17 (73.9) 14366.2 16 (69.6) 1142 7 (30.4) 100.2 7 (30.4) 202.7
* 1 ICT positive (South-west1 site) did not participate to the night blood examination.
doi:10.1371/journal.pntd.0004184.t003
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Table 4. Comparison of day and night parasitological indices in lymphoedema cases.
L. loa Mf M. perstans Mf
Day Night Day Night
Examined
(n)
Mf positive
(%)
Mf GMI (Mf/
ml)
Mf positive
(%)
Mf GMI (Mf/
ml)
Mf positive
(%)
Mf GMI (Mf/
ml)
Mf positive
(%)
Mf GMI (Mf/
ml)
Health districts
East
Batouri-HD 2 0 - 0 - 0 - 0 -
Messamena-
HD
7 5 161.7 1 1060 6 494.4 5 562.8
North-west
Nwa-HD 11 6 341.1 1 60 0 - 0 -
Total 20 11 (55) 243.0 2 (10) 252.2 6 (30) 494.4 5 (25) 562.8
doi:10.1371/journal.pntd.0004184.t004
Table 5. L. loa andM. perstansMf periodicity with respect to microfilarial load ranges of ICT positive individuals.
L. loa Mf M. perstans Mf
Mf load ranges (Mf/ml) Examined (n) Day+/ Night+ Day+/ Night- Day-/Night- Day-/Night+ Examined (n) Day+/ Night+ Day-/Night-
0 6 0 0 5 1 16 0 16
1–8000 3 2 1 0 0 7 7 0
8001–30000 9 8 1 0 0 0 0 0
> 30000 5 5 0 0 0 0 0 0
Total 23 15 2 5 1 23 7 16
doi:10.1371/journal.pntd.0004184.t005
Table 6. L. loa andM. perstansMf periodicity with respect to microfilarial load ranges of lymphoedema cases.
L. loa Mf Examined (n) M. perstans Mf
Mf load ranges (Mf/ml) Examined (n) Day+/ Night+ Day+/ Night- Day-/Night- Day+/ Night+ Day+/Night- Day-/Night-
0 9 0 0 9 14 0 0 14
1–8000 11 2 9 0 6 5 1 0
Total 20 2 9 9 20 5 1 14
doi:10.1371/journal.pntd.0004184.t006
Table 7. Infection profile of ICT positives cases with respect to L. loa andM. perstans infection status using day blood.
Infection status
Health district Examined (n) Loa+/Pers+ Loa+/Pers- Loa-/Pers- Loa-/Pers+
East-Batouri 6 6 0 0 0
East-Messamena 4 1 0 3 0
Northwest-Nwa 13 0 10 3 0
Southwest 1—Kumba 1 1 0 0 0
Total 24 8 10 6 0
doi:10.1371/journal.pntd.0004184.t007
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(areas under ivermectin MDA). ICT positivity was significantly associated to the L. loaMf pos-
itivity (p< 0.001) with 18 L. loaMf positive individuals out of the 24 ICT positives. There was
no association between ICT positivity and the positivity ofM. perstansMf (p = 0.211). Only 8
ICT positives wereM. perstansMf positive and they were all L. loaMf carriers. Lymphoedema
cases were all ICT negatives and the majority of them neither have L. loa norM. perstansMf
(Table 8).
Individual-level association between ICT positivity and L. loa/M.
perstans Mf intensities
The prevalence of ICT positivity was strongly correlated with Mf loads of L. loa (Table 9). Only
0.3% of amicrofilaremic individuals were ICT positive. One percent of L. loaMf carriers with
low Mf load (1–8000 Mf/ml of blood) were ICT positive. Meanwhile, 20.4% and 41.7% of carri-
ers of high (8001–30000 Mf/ml of blood) and very high (> 30,000 Mf/ml of blood) of L. loa
had a positive ICT result respectively.
This strong association was further confirmed in a logistic regression analysis where it was
demonstrated that harbouring L. loaMf in the blood was a good predictor for having a positive
ICT result (Odds Ratio = 15.4; 95% CI: 6.1–39.0; p< 0.001). The odds of an individual with
high Mf load of L. loa (8001–30000 Mf/ml) to be detected CFA positive by ICT, is 77.4 times
higher than an amicrofilaremic individual (OR = 77.4; 95% CI: 26.8–223.7; p< 0.001). The OR
becomes extremely high (OR = 215.7; 95% CI: 53.2–874.6; p< 0.001), when an individual har-
bours very high Mf loads of L. loa (> 30,000 Mf/ml of blood) (Tables 10 and 11).
District-level association between ICT prevalence and L. loa/M. perstans
Mf prevalence
The ICT prevalence was strongly correlated (Spearman’s rho = 0.900; p< 0.05) with the
endemicity level of loiasis in the different sites as illustrated in Fig 4. ICT positivity was very rare
Table 8. Infection profile of lymphoedema cases with respect to L. loa andM. perstans infection status using day blood.
Infection status
Health district Examined (n) Loa+/Pers+ Loa+/Pers- Loa-/Pers- Loa-/Pers+
East-Batouri 2 0 0 2 0
East-Messamena 7 5 0 1 1
Northwest-Nwa 11 0 6 5 0
Total 20 5 6 8 1
doi:10.1371/journal.pntd.0004184.t008
Table 9. Percentage of positive results using ICT card according to the L. loa load of microfilariae.
ICT card
Microﬁlariae/mL of blood Positives % Negatives Total
0 6 0.3 1812 1818
1–8000 3 1.0 308 311
8001–30000 10 20.4 39 49
> 30000 5 41.7 7 12
R = 0.438; p < 0.001
doi:10.1371/journal.pntd.0004184.t009
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or low in areas where L. loaMf prevalence was below 10%. A positive ICT prevalence of ICT up
to 0.8% could be seen in areas where the L. loaMf prevalence ranged between 10–15%. When
prevalence rates of L. loaMf were above 25%, rates of more than 1% of ICT positives were
detected. In contrast, there was no significant correlation between the prevalence of positive
ICT andM. perstansMf prevalence (Spearman’s rho = - 0.200; p = 0.747) as illustrated in Fig 5.
Discussion
The ICT has been extensively used to map LF caused byW. bancrofti in Asia, Latin America,
and North, West and East Africa. Most of these surveys were conducted in loiasis non-endemic
areas [20,33–36]. Furthermore, in most areas the ICT was used as sole diagnostic test for rou-
tine mapping and was rarely confirmed by additional diagnostic procedures; such as the night
TBF and microscopic examination to confirm the presence ofW. bancroftiMf in the peripheral
blood. The present study is the first to evaluate in detail the specificity of the ICT in areas with
contrasting endemicity levels of loiasis and mansonellosis in Cameroon.
The Mf results obtained for L. loa andM. perstansMf prevalence were in agreement with
previous studies [37–41]. The difference in L. loaMf prevalence observed in the East sites can
be attributed to the impact of ivermectin MDA on loiasis parasitological indices, since annual
community directed treatment with ivermectin (CDTI) is ongoing in Messamena-HD for
almost 10 years while Batouri-HD is a CDTI naïve area.
The ICT identified 1.1% (24/2190)W. bancrofti amicrofilaremic individuals as positive for
circulating filarial antigen. The North-west and East sites showed a higher rate of positive ICT
(2.1% and 1.2% of ICT positive tests respectively). Night blood examination results revealed the
presence of two other blood dwelling Mf, L. loa andM. perstans known as endemic in the rain-
forest domain of Africa. These results are in line with previous ones, where a high sensitivity of
Table 11. Logistic regression analysis of ICT results according to L. loa load among the Mf carriers.
ICT Results Statistics
L. loa Mf load (Mf/ml) Positive Negative Total OR 95%CI P-value
1–8,000 3 (1) 308(99) 311 2.9 0.7–11.8 0.128
8,001–30,000 10 (20.4) 39(79.6) 49 77.4 26.8–223.7 < 0.001
> 30,000 5 (41.7) 7(58.3) 12 215.7 53.2–874.6 < 0.000
Numbers in brackets are percentages.
doi:10.1371/journal.pntd.0004184.t011
Table 10. Association between ICT results and L. loa /M. perstans positivity rates.
ICT Results Statistics
Positive Negative Total OR 95%CI P-value
L. loa Mf
L. loa Mf + 18(4.8) 354 (95.2) 372 15.4 6.1–39.0 < 0.001
L. loa Mf - 6 (0.3) 1812(99.7) 1818 - - -
M. perstans
M. perstans Mf + 8 (1.6) 478 (98.4) 486 1.8 0.8–4.2 0.192
M. perstans Mf - 16 (0.9) 1688 (99.1) 1704 - - -
Numbers in brackets are percentages.
doi:10.1371/journal.pntd.0004184.t010
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ICT at detecting Loa-microfilaremic patients was observed in the Democratic Republic of Congo
[24]. The only clinical manifestation that may related to LF in the present study was lymphoe-
dema. This has been reported by several investigators as the cause of disability and disfigurement
in endemic areas [42–44]. Twenty (0.9%) lymphoedema cases were diagnosed and none of them
were tested positive by ICT or found harbouringW. bancroftiMf in their night blood. The
majority of the lymphoedema cases were found in the North-west site (11/20). Other studies
have reported lymphoedema cases of non-filarial origin in the North-west region of Cameroon.
This condition (podoconiosis) is caused by irritating micro-particles from the soil [45].
During this study, the infection profile of ICT positives clearly indicates high L. loaMf rates
(73.9%) compared to a relatively low prevalence rates ofM. perstansMf (30.4%). More than
65% of L. loaMf carriers in this group had high (> 8,000 Mf/ml) and very high (> 30,000 Mf/
ml) Mf loads, whileM. perstansMf had low densities (1–8,000 Mf/ml). On the other hand, low
Mf densities and prevalence were observed for the lymphoedema cases. This confirms that
lymphoedema is not associated with loiasis or mansonellosis.
A decrease of L. loaMf prevalence occurs between day and night TBF Mf carriers with low
Mf loads, contrary to high Mf carriers, whose prevalence remains practically the same.Manso-
nella perstansMf prevalence did not vary between the day and night thick blood smears
Fig 4. Correlation between ICT positivity rate and L. loaMf prevalence.
doi:10.1371/journal.pntd.0004184.g004
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diagnosis. More studies are necessary to better estimate threshold values of Mf densities at
which L. loaMf prevalence is not influenced by the time of blood collection.
None of the ICT positives was infected withM. perstansMf only. Among the 17 Mf positive
individuals, 10 had L. loa single infections and 8 were co-infected with both L. loa andM. per-
stans. The remaining 6 ICT positive individuals were amicrofilaremic for both parasites. This
last group of individuals was recruited from areas of intermediate to high endemicity level of
loiasis (East-Messamena and North-west) under implementation of community-directed treat-
ment with ivermectin (9 and 8 rounds of treatment respectively). They might harbour other
parasites or stages of filarial species (especially adult worms) responsible of the ICT positivity
observed, since the study was carried out few months after the MDA. InW. bancrofti infections,
antigenaemia is common in amicrofilaremic individuals [14]. It is assumed that, the ICT is
detecting circulating adult worm antigen, and high Mf levels are usually associated with more
adult worms that shed antigen. Further studies to investigate the extent of the ICT card cross-
reactivity with different stages of filarial parasites through in vitromaintenance may be helpful.
An association between ICT positivity rate and loiasis/mansonellosis prevalence was ana-
lysed using spearman correlation analysis. ICT rate was strongly correlated with loiasis
endemicity level. Moreover, this model indicated that for L. loaMf prevalence greater than
4.3%, there is a possibility to detect ICT positivity related to loiasis. In contrast, no correlation
Fig 5. Correlation between ICT positivity rate andM. perstansMf prevalence.
doi:10.1371/journal.pntd.0004184.g005
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was observed between the ICT positivity rate andM. perstansMf prevalence. Henceforth, the
logistic regression analysis indicated an association between ICT positivity and L. loaMf den-
sity. This association was significant for individuals carrying high and very high Mf loads. This
observation was previously made by Pion et al. [31] who demonstrated a relationship between
high L. loaMf density and ICT positivity while mapping LF in area with loiasis in the South
region of Cameroon. These observations put together, raise the question whether the ICT can
be modified to detect individuals at risk of severe adverse reactions due to high L. loaMf densi-
ties during ivermectin MDA.
Another implication of our observations is that the LF map in the central African region
needs validation taking into consideration the endemicity of L. loa. Recently, an improved
rapid format antigen detection test that uses the same principal reagents as the ICT was devel-
oped. This new Alere filariasis test strip is more sensitive compared to the ICT, uses a smaller
volume of blood, has a longer shelf time, and will be significantly cheaper [24,25]. This new test
has been endorsed by GPELF and will replace the ICT in the near future. The problem of
cross-reactivity with loiasis observed with ICT is likely to remain with the new Alere filariasis
test strip. The Cameroon LF map based on ICT considerably overlaps the geographic distribu-
tion of L. loa. However, the environmental suitability for LF transmission in Cameroon seems
not in good agreement with the LF map based on ICT [46]. Therefore, an algorithm for LF
mapping in loiasis co-endemic areas would be helpful to validate the ICT map of LF in Central
Africa. Furthermore, with the expansion of MDA for LF elimination in Africa to areas co-
endemic for loiasis, it is crucial to select appropriate diagnostic tools for monitoring and evalu-
ation of the elimination program. Transmission assessment surveys based on ICT alone as rec-
ommended by WHOmay not be suitable for areas co-endemic with L. loa. Our study has
shown the need of confirmatory tests for LF detection to supplement the ICT in areas highly
endemic for loiasis.
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